PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
公司代碼PRCT
公司名稱Procept Biorobotics Corp
上市日期Sep 15, 2021
CEOWood (Larry L)
員工數量756
證券類型Ordinary Share
年結日Sep 15
公司地址150 Baytech Drive
城市SAN JOSE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編95134
電話16502329832
網址https://www.procept-biorobotics.com/
公司代碼PRCT
上市日期Sep 15, 2021
CEOWood (Larry L)